Compositions and methods for drug sensitization of parasites

US11083717B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11083717-B2
Application numberUS-201916720160-A
CountryUS
Kind codeB2
Filing dateDec 19, 2019
Priority dateAug 26, 2015
Publication dateAug 10, 2021
Grant dateAug 10, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compositions and methods for inhibiting and/or sensitizing or re-sensitizing a parasite to an antiparasitic drug are provided. The compositions can comprise a an arylphenoxypropionate derivative, an aryloxyphenoxyacetate derivative, an aryloxyphenylacetate derivative, one or more substituted quinols, or a pharmaceutically acceptable salt, hydrate, or prodrug thereof, or a combination thereof in an amount and formulation sufficient to sensitize the parasite to the drug, treating infection of a patient by a parasite with a drug, or to prevent symptomatic infection of a patient by a parasite with a drug.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of inhibiting a parasite, comprising administering an arylphenoxypropionate derivative, an aryloxyphenoxyacetate derivative, an aryloxyphenylacetate derivative, one or more substituted quinols, or a pharmaceutically acceptable salt, hydrate, or prodrug thereof, or a combination thereof directly to the parasite in an amount and for a time sufficient to inhibit the parasite in an animal. 2. The method of claim 1 , further comprising administering an arylphenoxypropionate derivative, an aryloxyphenoxyacetate derivative, an aryloxyphenylacetate derivative, one or more substituted quinols, or a pharmaceutically acceptable salt, hydrate, or prodrug thereof, or a combination thereof directly to the parasite a second or greater time. 3. The method of claim 2 , wherein the parasite is a species of the genus Plasmodium , a species of the genus Ascaris , a species of the genus Enterobius , a species of the genus Trichinella , a species of the genus Haemonchus , a species of the genus Aphelenchoides , a species of the genus Ditylenchus , a species of the genus Globodera , a species of the genus Heterodera , a species of the genus Longidorus , a species of the genus Meloidogyne , a species of the genus Nacobbus , a species of the genus Pratylenchus , a species of the genus Trichodorus , a species of the genus Xiphinema , a species of the genus Bursaphelenchus , a species of the genus Fasciola , a species of the genus Coccidoides , or a species of the genus Onchocerca. 4. The method of claim 2 , wherein the parasite is selected from the group consisting of Pedicululs humanus, Phthiriasis pubis, Sarcoptes scabiei, Schistosoma mansoni, Schistosoma japonicum, Schistosoma haemotobium, Trichobilharzia regenti, Clonorchis simensis, Fasciola hepatica, Fasciola gigantica, Opisthorchis viverrinil, Paragonimus westermani, Paragonimus kellicotti, Fasciolopsis buski, Metagonimus yokagawai, Heterophyes heterophyes, Echinococcus granulosus, Echinococcus multilocularis, Taenia saginata, Taenia solium, Taenia asiatica, Hymenolpeis nana, Hymenolpeis diminuta, Diphyllobotrium latum, Diphyllobotrium mansonoides, Spirometra erinaceieuropaei, Dracunculus medinensis, Onchocerca volvulus, Lo vaginalis a loa, Mansonella perstans, Mansonella ozzardi, Mansonella streptocera, Wucheria bancrofti, Brugia malayi, Brugia timori, Gnathostoma spinigerum, Gnathostoma hispidium, Ancylostoma duodenale, Ancylostoma brazilienes, Necator americanus, Angiostrongylus cantonensis, Ascaris lumbricoides, Toxocara canis, Toxocara cati, Strongyloides stercoralis, Enterobius vermicularis, Trichinella spiralis, Trichuris trichiura, Cryptosporidium hominis, Cryptosporidium parvum, Isosporiasis befii, Cyclospora cayetanesis, Toxoplasma gondii, Balantidium coli, Entamoeba histolytica, dispar, Giardia lamblia, Trichmonas vaginalis, Dientamoeba fragilis, Blastocystis hominis, Plasmodium falciparum, Plasmodium vivax, Plasmodium ovate, Plasmodium malariea, Babesia divergens, Babesia microfti, Trypanosoma brucei, Trypanosoma cruzi, Leishomania mexicana, Leishomania aethiopica, Leishomania tropic, Leishomania braziliensis, Leishomania donovani , and Leishomania infantum, Eimeria vermiformis, Eimeria brunett, Eimeria praecox, Eimeria maxima, Eimeria mitis, Eimeria necatrix and Eimeria tenefla. 5. The method of claim 1 , wherein the arylphenoxypropionate derivative is NZ-369. 6. The method of claim 5 , wherein the parasite is a species of the genus Plasmodium , a species of the genus Ascaris , a species of the genus Enterobius , a species of the genus Trichinella , a species of the genus Haemonchus , a species of the genus Aphelenchoides , a species of the genus Ditylenchus , a species of the genus Globodera , a species of the genus Heterodera , a species of the genus Longidorus , a species of the genus Meloidogyne , a species of the genus Nacobbus , a species of the genus Pratylenchus , a species of the genus Trichodorus , a species of the genus Xiphinema , a species of the genus Bursaphelenchus , a species of the genus Fasciola , a species of the genus Coccidoides , or a species of the genus Onchocerca. 7. The method of claim 5 , wherein the parasite is selected from the group consisting of Pedicululs humanus, Phthiriasis pubis, Sarcoptes scabiei, Schistosoma mansoni, Schistosoma japonicum, Schistosoma haemotobium, Trichobilharzia regenti, Clonorchis simensis, Fasciola hepatica, Fasciola gigantica, Opisthorchis viverrinil, Paragonimus westermani, Paragonimus kellicotti, Fasciolopsis buski, Metagonimus yokagawai, Heterophyes heterophyes, Echinococcus granulosus, Echinococcus multilocularis, Taenia saginata, Taenia solium, Taenia asiatica, Hymenolpeis nana, Hymenolpeis diminuta, Diphyllobotrium latum, Diphyllobotrium mansonoides, Spirometra erinaceieuropaei, Dracunculus medinensis, Onchocerca volvulus, Lo vaginalis a boa, Mansonella perstans, Mansonella ozzardi, Mansonella streptocera, Wucheria bancrofti, Brugia malayi, Brugia timori, Gnathostoma spinigerum, Gnathostoma hispidium, Ancylostoma duodenale, Ancylostoma brazilienes, Necator americanus, Angiostrongylus cantonensis, Ascaris lumbricoides, Toxocara canis, Toxocara cati, Strongyloides stercoralis, Enterobius vermicularis, Trichinella spiralis, Trichuris trichiura, Cryptosporidium hominis, Cryptosporidium parvum, Isosporiasis befii, Cyclospora cayetanesis, Toxoplasma gondii, Balantidium coli, Entamoeba histolytica, dispar, Giardia lamblia, Trichmonas vaginalis, Dientamoeba fragilis, Blastocystis hominis, Plasmodium falciparum, Plasmodium vivax, Plasmodium ovate, Plasmodium malariea, Babesia divergens, Babesia microfti, Trypanosoma brucei, Trypanosoma cruzi, Leishomania mexicana, Leishomania aethiopica, Leishomania tropic, Leishomania braziliensis, Leishomania donovani , and Leishomania infantum, Eimeria vermiformis, Eimeria brunett, Eimeria praecox, Eimeria maxima, Eimeria mitis, Eimeria necatrix and Eimeria tenefla. 8. The method of claim 1 , wherein the parasite is a species of the genus Plasmodium , a species of the genus Ascaris , a species of the genus Enterobius , a species of the genus Trichinella , a species of the genus Haemonchus , a species of the genus Aphelenchoides , a species of the genus Ditylenchus , a species of the genus Globodera , a species of the genus Heterodera , a species of the genus Longidorus , a species of the genus Meloidogyne , a species of the genus Nacobbus , a species of the genus Pratylenchus , a species of the genus Trichodorus , a species of the genus Xiphinema , a species of the genus Bursaphelenchus , a species of the genus Fasciola , a species of the genus Coccidoides , or a species of the genus Onchocerca. 9. The method of claim 1 , wherein the parasite is selected from the group consisting of Pedicululs humanus, Phthiriasis pubis, Sarcoptes scabiei, Schistosoma mansoni, Schistosoma japonicum, Schistosoma haemotobium, Trichobilharzia regenti, Clonorchis simensis, Fasciola hepatica, Fasciola gigantica, Opisthorchis viverrinil, Paragonimus westermani, Paragonimus kellicotti, Fasciolopsis buski, Metagonimus yokagawai, Heterophyes heterophyes, Echinococcus granulosus, Echinococcus multilocularis, Taenia saginata, Taenia solium, Taenia asiatica, Hymenolpeis nana, Hymenolpeis diminuta, Diphyllobotrium latum, Diphyllobotrium mansonoides, Spirometra erinaceieuropaei, Dracunculus medinensis, Onchocerca volvulus, Lo vaginalis a boa, Mansonella perstans, Mansonella ozzardi, Mansonella streptocera, Wucheria bancrofti, Brugia malayi, Brugia timori, Gnathostoma spinigerum, Gnathostoma hispidium, Ancylostoma duodenale, Ancylostoma brazilienes, Necator americanus, Angiostrongylus cantonensis, Ascaris lumbricoides, Toxocara canis, Toxocara cati,

Assignees

Inventors

Classifications

  • condensed with carbocyclic rings · CPC title

  • not condensed and containing further heterocyclic rings, e.g. timolol · CPC title

  • 3,4-Dihydrobenzopyrans, e.g. chroman, catechin · CPC title

  • containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K31/465) · CPC title

  • having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11083717B2 cover?
Compositions and methods for inhibiting and/or sensitizing or re-sensitizing a parasite to an antiparasitic drug are provided. The compositions can comprise a an arylphenoxypropionate derivative, an aryloxyphenoxyacetate derivative, an aryloxyphenylacetate derivative, one or more substituted quinols, or a pharmaceutically acceptable salt, hydrate, or prodrug thereof, or a combination thereof in…
Who is the assignee on this patent?
Texas A & M Univ Sys
What technology area does this patent fall under?
Primary CPC classification A61K31/44. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).